Published in Clin Rheumatol on May 22, 2012
Macrophage activation syndrome and cytokine-directed therapies. Best Pract Res Clin Rheumatol (2014) 1.06
Reactive hemophagocytic syndrome in adult-onset Still disease: clinical features, predictive factors, and prognosis in 21 patients. Medicine (Baltimore) (2015) 0.91
Successful control of juvenile dermatomyositis-associated macrophage activation syndrome and interstitial pneumonia: distinct kinetics of interleukin-6 and -18 levels. Pediatr Rheumatol Online J (2015) 0.79
Hemophagocytic lymphohistiocytosis in a patient with Goodpasture's syndrome: a rare clinical association. Am J Case Rep (2014) 0.79
Pancytopenia as an early indicator for Stevens-Johnson syndrome complicated with hemophagocytic lymphohistiocytosis: a case report. BMC Pediatr (2014) 0.78
Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus. Rheumatol Int (2016) 0.78
Evidence-based diagnosis and treatment of macrophage activation syndrome in systemic juvenile idiopathic arthritis. Pediatr Rheumatol Online J (2015) 0.76
Macrophage activation syndrome in a newborn infant born to a mother with autoimmune disease. J Perinatol (2015) 0.75
Forme Fruste of HLH (haemophagocytic lymphohistiocytosis): diagnostic and therapeutic challenges. BMJ Case Rep (2015) 0.75
New frontiers in the treatment of systemic juvenile idiopathic arthritis. F1000Res (2017) 0.75
Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum (1997) 43.47
HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer (2007) 16.96
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost (2006) 16.11
Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost (2001) 6.16
Systemic lupus erythematosus disease activity index 2000. J Rheumatol (2002) 6.11
Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science (1999) 4.93
Current proposed revision of JRA Criteria. JRA Criteria Subcommittee of the Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Section of The Arthritis Foundation. Arthritis Rheum (1977) 3.51
Macrophage activation syndrome: experience from a tertiary referral centre. J Assoc Physicians India (2007) 2.73
The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis. Arthritis Rheum (2007) 2.56
Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders. Arch Dis Child (2001) 2.11
Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. J Rheumatol (2007) 1.93
Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. J Pediatr (2005) 1.91
Macrophage activation syndrome following initiation of etanercept in a child with systemic onset juvenile rheumatoid arthritis. J Rheumatol (2003) 1.90
Prognostic factors of hemophagocytic syndrome in adults: analysis of 34 cases. Eur J Haematol (1997) 1.54
Rapid and sustained remission of systemic juvenile idiopathic arthritis-associated macrophage activation syndrome through treatment with anakinra and corticosteroids. J Clin Rheumatol (2011) 1.51
Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients. Rheumatology (Oxford) (2001) 1.48
Clinical features of haemophagocytic syndrome in patients with systemic autoimmune diseases: analysis of 30 cases. Rheumatology (Oxford) (2008) 1.48
Macrophage activation syndrome in juvenile systemic lupus erythematosus: a multinational multicenter study of thirty-eight patients. Arthritis Rheum (2009) 1.47
Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: possible relationship to drugs or infection. J Pediatr (1985) 1.43
Safety of intravenous immunoglobulin (IVIG) therapy. Autoimmun Rev (2006) 1.39
Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome. Arthritis Res Ther (2004) 1.33
Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms. Arthritis Rheum (2008) 1.33
Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine. J Pediatr (1996) 1.23
Kawasaki disease followed by haemophagocytic syndrome. Eur J Pediatr (1998) 1.15
Macrophage activation syndrome--what's in a name! J Rheumatol (2003) 1.10
Autoimmune-associated hemophagocytic syndrome. Mod Rheumatol (2004) 1.07
Mutations of the hemophagocytic lymphohistiocytosis-associated gene UNC13D in a patient with systemic juvenile idiopathic arthritis. Arthritis Rheum (2008) 1.05
Macrophage activation syndrome in autoimmune disease. Int Arch Allergy Immunol (2010) 1.04
RANTES and monocyte chemoattractant protein 1 as sensitive markers of disease activity in patients with juvenile rheumatoid arthritis: a six-year longitudinal study. Arthritis Rheum (2006) 0.99
The pathogenesis of oligoarticular/polyarticular vs systemic juvenile idiopathic arthritis. Autoimmun Rev (2011) 0.96
Successful treatment of cytomegalovirus-associated hemophagocytic syndrome by intravenous immunoglobulins. Am J Hematol (2008) 0.96
Cytokine profiles of macrophage activation syndrome associated with rheumatic diseases. J Rheumatol (2010) 0.90
Neuropsychiatric manifestations in pediatric systemic lupus erythematosus: a 20-year study. Lupus (2006) 0.90
Platelet-specific hemophagocytosis in a patient with juvenile dermatomyositis. Acta Paediatr (2000) 0.82
[A case of mixed connective tissue disease successfully treated for hemophagocytic syndrome with intermittent intravenous injection of cyclophosphamide]. Nihon Rinsho Meneki Gakkai Kaishi (2004) 0.78
Macrophage activation syndrome in children with systemic onset juvenile idiopathic arthritis: clinical experience from northwest India. Rheumatol Int (2011) 0.76
Monitoring serum IL-18 levels is useful for treatment of a patient with systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome. Pediatr Rheumatol Online J (2011) 0.76
Macrophage activation syndrome as an early presentation of Lupus. J Rheumatol (2006) 0.75
Childhood macrophage activation syndrome differs from infection-associated hemophagocytosis syndrome in etiology and outcome in Taiwan. J Microbiol Immunol Infect (2007) 0.75
Proposed disease activity criteria for mixed connective tissue disease. Lupus (2009) 0.75
Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination. Hepatology (2004) 2.74
Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials. J Bone Joint Surg Am (2004) 2.57
Epidemiologic features of Kawasaki disease in Taiwan, 2003-2006. Pediatrics (2009) 1.85
Status of cellular rather than humoral immunity is correlated with clinical outcome of enterovirus 71. Pediatr Res (2006) 1.50
Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization. J Infect Dis (2008) 1.43
Quantitative assessment of allergic shiners in children with allergic rhinitis. J Allergy Clin Immunol (2009) 1.41
Antitumor and antimetastatic activity of IL-23. J Immunol (2003) 1.38
Inverse correlation between CD4+ regulatory T-cell population and autoantibody levels in paediatric patients with systemic lupus erythematosus. Immunology (2006) 1.21
Polysaccharide purified from Ganoderma lucidum induced activation and maturation of human monocyte-derived dendritic cells by the NF-kappaB and p38 mitogen-activated protein kinase pathways. J Leukoc Biol (2005) 1.20
Clinical characteristics of childhood erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in Taiwanese children. J Microbiol Immunol Infect (2004) 1.20
Increased killing activity and decreased cytokine production in NK cells in patients with primary biliary cirrhosis. J Autoimmun (2006) 1.17
Epidemiologic features of Kawasaki disease in Taiwan, 1996-2002. Pediatrics (2004) 1.15
Innate immunity and primary biliary cirrhosis: activated invariant natural killer T cells exacerbate murine autoimmune cholangitis and fibrosis. Hepatology (2011) 1.15
The immunobiology of Henoch-Schönlein purpura. Autoimmun Rev (2007) 1.13
Oral immunization of mice using transgenic tomato fruit expressing VP1 protein from enterovirus 71. Vaccine (2006) 1.13
Roles of keratinocyte inflammation in oral cancer: regulating the prostaglandin E2, interleukin-6 and TNF-alpha production of oral epithelial cells by areca nut extract and arecoline. Carcinogenesis (2003) 1.12
Proteomics and immunological analysis of a novel shrimp allergen, Pen m 2. J Immunol (2003) 1.12
Altered homeostasis of CD4(+) FoxP3(+) regulatory T-cell subpopulations in systemic lupus erythematosus. Immunology (2008) 1.09
FIC1 and BSEP defects in Taiwanese patients with chronic intrahepatic cholestasis with low gamma-glutamyltranspeptidase levels. J Pediatr (2002) 1.08
Clinical manifestations and outcomes of Henoch-Schönlein purpura: comparison between adults and children. Pediatr Neonatol (2009) 1.07
Enterovirus 71 virus-like particle vaccine: improved production conditions for enhanced yield. Vaccine (2010) 1.07
Enterovirus type 71 neutralizing antibodies in the serum of macaque monkeys immunized with EV71 virus-like particles. Vaccine (2011) 1.02
Proteome mining for novel IgE-binding proteins from the German cockroach (Blattella germanica) and allergen profiling of patients. Proteomics (2010) 1.01
Increased levels of chemokine receptor CXCR3 and chemokines IP-10 and MIG in patients with primary biliary cirrhosis and their first degree relatives. J Autoimmun (2005) 1.00
Staphylococcus colonization in atopic dermatitis treated with fluticasone or tacrolimus with or without antibiotics. Ann Allergy Asthma Immunol (2007) 0.99
Outcome of patients with esophageal cancer: a nationwide analysis. Ann Surg Oncol (2013) 0.99
Morin sulfates/glucuronides exert anti-inflammatory activity on activated macrophages and decreased the incidence of septic shock. Life Sci (2003) 0.99
Necrotizing pneumococcal pneumonia in children: the role of pulmonary gangrene. Pediatr Pulmonol (2006) 0.99
Epidemiology of respiratory syncytial virus infection in northern Taiwan, 2001-2005 -- seasonality, clinical characteristics, and disease burden. J Microbiol Immunol Infect (2007) 0.98
Clinical manifestations and inflammatory cytokine responses in patients with severe acute respiratory syndrome. J Formos Med Assoc (2005) 0.97
The pathogenesis of oligoarticular/polyarticular vs systemic juvenile idiopathic arthritis. Autoimmun Rev (2011) 0.96
The protease allergen Pen c 13 induces allergic airway inflammation and changes in epithelial barrier integrity and function in a murine model. J Biol Chem (2011) 0.95
Impact of maternal and neonatal factors on CD34+ cell count, total nucleated cells, and volume of cord blood. Pediatr Transplant (2008) 0.95
An immunomodulatory protein, Ling Zhi-8, induced activation and maturation of human monocyte-derived dendritic cells by the NF-kappaB and MAPK pathways. J Leukoc Biol (2009) 0.94
Regulatory T cells negatively regulate neovasculature of airway remodeling via DLL4-Notch signaling. J Immunol (2009) 0.94
Patient data, early SARS epidemic, Taiwan. Emerg Infect Dis (2004) 0.94
A new insight into hepatitis C vaccine development. J Biomed Biotechnol (2010) 0.94
Renal manifestations in Henoch-Schönlein purpura: a 10-year clinical study. Pediatr Nephrol (2005) 0.93
Juvenile idiopathic arthritis-associated uveitis: a nationwide population-based study in Taiwan. PLoS One (2013) 0.93
Shikonin inhibits maturation of bone marrow-derived dendritic cells and suppresses allergic airway inflammation in a murine model of asthma. Br J Pharmacol (2010) 0.92
A novel phycobiliprotein alleviates allergic airway inflammation by modulating immune responses. Am J Respir Crit Care Med (2010) 0.92
Sex differences in spontaneous versus induced animal models of autoimmunity. Autoimmun Rev (2011) 0.92
Lentiviral-mediated GATA-3 RNAi decreases allergic airway inflammation and hyperresponsiveness. Mol Ther (2007) 0.91
Over-expression of receptor activator of nuclear factor-kappaB ligand (RANKL), inflammatory cytokines, and chemokines in periprosthetic osteolysis of loosened total hip arthroplasty. Biomaterials (2009) 0.91
Propolis extracts exhibit an immunoregulatory activity in an OVA-sensitized airway inflammatory animal model. Int Immunopharmacol (2006) 0.91
Methimazole-induced lupus erythematosus: a case report. J Microbiol Immunol Infect (2003) 0.91
Prostaglandin E2 potentiates mesenchymal stem cell-induced IL-10+IFN-γ+CD4+ regulatory T cells to control transplant arteriosclerosis. J Immunol (2013) 0.91
Increased levels of serum-specific immunoglobulin e to staphylococcal enterotoxin a and B in patients with allergic rhinitis and bronchial asthma. Int Arch Allergy Immunol (2005) 0.90
Lack of association between infection with a novel human coronavirus (HCoV), HCoV-NH, and Kawasaki disease in Taiwan. J Infect Dis (2005) 0.90
Retrospective analysis of mortality and morbidity of pediatric systemic lupus erythematosus in the past two decades. J Microbiol Immunol Infect (2003) 0.90
Correlation between age and allergens in pediatric atopic dermatitis. Ann Allergy Asthma Immunol (2004) 0.89
Genetics and immunopathogenesis of IgA nephropathy. Clin Rev Allergy Immunol (2011) 0.89
Regulatory T cells induced by mucosal B cells alleviate allergic airway hypersensitivity. Am J Respir Cell Mol Biol (2011) 0.89
Separation and detection of rare cells in a microfluidic disk via negative selection. Lab Chip (2010) 0.88
Prescription patterns of chinese herbal products for osteoporosis in taiwan: a population-based study. Evid Based Complement Alternat Med (2012) 0.88
Aortic aneurysm in systemic lupus erythematosus. J Microbiol Immunol Infect (2004) 0.88
Linoleic acid metabolite levels and transepidermal water loss in children with atopic dermatitis. Ann Allergy Asthma Immunol (2008) 0.88